"Antipsychotic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.
Descriptor ID |
D014150
|
MeSH Number(s) |
D27.505.696.277.950.040 D27.505.954.427.210.950.040 D27.505.954.427.700.872.331
|
Concept/Terms |
Antipsychotic Agents- Antipsychotic Agents
- Agents, Antipsychotic
- Antipsychotics
- Major Tranquilizers
- Tranquilizers, Major
- Tranquillizing Agents, Major
- Agents, Major Tranquillizing
- Major Tranquillizing Agents
- Neuroleptic Drugs
- Drugs, Neuroleptic
- Neuroleptics
- Tranquilizing Agents, Major
- Agents, Major Tranquilizing
- Major Tranquilizing Agents
- Antipsychotic Drugs
- Drugs, Antipsychotic
- Neuroleptic Agents
- Agents, Neuroleptic
Antipsychotic Effect- Antipsychotic Effect
- Effect, Antipsychotic
- Antipsychotic Effects
- Effects, Antipsychotic
|
Below are MeSH descriptors whose meaning is more general than "Antipsychotic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antipsychotic Agents".
This graph shows the total number of publications written about "Antipsychotic Agents" by people in this website by year, and whether "Antipsychotic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
2000 | 2 | 0 | 2 |
2001 | 1 | 1 | 2 |
2002 | 3 | 2 | 5 |
2003 | 2 | 1 | 3 |
2004 | 4 | 0 | 4 |
2005 | 6 | 1 | 7 |
2006 | 2 | 2 | 4 |
2007 | 4 | 0 | 4 |
2008 | 5 | 1 | 6 |
2009 | 1 | 2 | 3 |
2010 | 3 | 1 | 4 |
2011 | 1 | 1 | 2 |
2012 | 1 | 1 | 2 |
2013 | 4 | 3 | 7 |
2014 | 5 | 1 | 6 |
2015 | 1 | 1 | 2 |
2016 | 8 | 0 | 8 |
2017 | 4 | 3 | 7 |
2018 | 2 | 0 | 2 |
2020 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antipsychotic Agents" by people in Profiles.
-
Schnier C, McCarthy A, Morales DR, Akbari A, Sofat R, Dale C, Takhar R, Mamas MA, Khunti K, Zaccardi F, Sudlow CL, Wilkinson T. Antipsychotic drug prescribing and mortality in people with dementia before and during the COVID-19 pandemic: a retrospective cohort study in Wales, UK. Lancet Healthy Longev. 2023 08; 4(8):e421-e430.
-
Citrome L, Preskorn SH, Lauriello J, Krystal JH, Kakar R, Finman J, De Vivo M, Yocca FD, Risinger R, Rajachandran L. Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial. J Clin Psychiatry. 2022 10 03; 83(6).
-
McEvoy JP, Kremens DE. Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia. J Clin Psychiatry. 2020 Jan 28; 81(1).
-
Aggarwal A, Schrimpf L, Lauriello J. Aripiprazole Long-Acting Injectable for Maintenance Treatment of Bipolar I Disorder in Adults. Clin Schizophr Relat Psychoses. 2018 Jan; 11(4):221-223.
-
Correll CU, Lauriello J. Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan? J Clin Psychiatry. 2018 Jan/Feb; 79(1).
-
Foster A, Buckley P, Lauriello J, Looney S, Schooler N. Combination Antipsychotic Therapies: An Analysis From a Longitudinal Pragmatic Trial. J Clin Psychopharmacol. 2017 Oct; 37(5):595-599.
-
Rahman T, Ash DM, Lauriello J, Rawlani R. Misleading Guidance From Pharmacogenomic Testing. Am J Psychiatry. 2017 Oct 01; 174(10):922-924.
-
Correll CU, Citrome L, Haddad PM, Lauriello J, Olfson M, Kane JM. Dr Correll and Colleagues Reply. J Clin Psychiatry. 2017 Sep/Oct; 78(8):e1062.
-
Hock LE, Karnik NS. Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions. AMA J Ethics. 2017 Aug 01; 19(8):753-761.
-
Pillai A, Schooler NR, Peter D, Looney SW, Goff DC, Kopelowicz A, Lauriello J, Manschreck T, Mendelowitz A, Miller DD, Severe JB, Wilson DR, Ames D, Bustillo J, Kane JM, Buckley PF. Predicting relapse in schizophrenia: Is BDNF a plausible biological marker? Schizophr Res. 2018 03; 193:263-268.